Literature DB >> 27665752

Driving in Early-Stage Alzheimer's Disease: An Integrative Review of the Literature.

Rebecca L Davis, Jennifer M Ohman.   

Abstract

One of the most difficult decisions for individuals with Alzheimer's disease (AD) is when to stop driving. Because driving is a fundamental activity linked to socialization, independent functioning, and well-being, making the decision to stop driving is not easy. Cognitive decline in older adults can lead to getting lost while driving, difficulty detecting and avoiding hazards, as well as increased errors while driving due to compromised judgment and difficulty in making decisions. The purpose of the current literature review was to synthesize evidence regarding how individuals with early-stage AD, their families, and providers make determinations about driving safety, interventions to increase driving safety, and methods to assist cessation and coping for individuals with early-stage AD. The evidence shows that changes in driving ability start early and progress throughout the trajectory of AD. Some individuals with mild cognitive impairment or early-stage AD may be safe to drive for a period of time. Support groups aimed at helping with the transition have been shown to be helpful for individuals who stop driving. Research and practice must support interventions to help individuals maintain safety while driving, as well as cope with driving cessation. [Res Gerontol Nurs. 2017; 10(2):86-100.]. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Year:  2016        PMID: 27665752     DOI: 10.3928/19404921-20160920-02

Source DB:  PubMed          Journal:  Res Gerontol Nurs        ISSN: 1938-2464            Impact factor:   1.571


  7 in total

Review 1.  Decision-Making Competence in Patients with Alzheimer's Disease: A Review of the Literature.

Authors:  Fanny Gaubert; Hanna Chainay
Journal:  Neuropsychol Rev       Date:  2021-02-12       Impact factor: 7.444

2.  A Naturalistic Study of Driving Behavior in Older Adults and Preclinical Alzheimer Disease: A Pilot Study.

Authors:  Ganesh M Babulal; Sarah H Stout; Tammie L S Benzinger; Brian R Ott; David B Carr; Mollie Webb; Cindy M Traub; Aaron Addison; John C Morris; David K Warren; Catherine M Roe
Journal:  J Appl Gerontol       Date:  2017-01-29

3.  Adverse driving behaviors are associated with sleep apnea severity and age in cognitively normal older adults at risk for Alzheimer's disease.

Authors:  Jason M Doherty; Catherine M Roe; Samantha A Murphy; Ann M Johnson; Ella Fleischer; Cristina D Toedebusch; Tiara Redrick; David Freund; John C Morris; Suzanne E Schindler; Anne M Fagan; David M Holtzman; Brendan P Lucey; Ganesh M Babulal
Journal:  Sleep       Date:  2022-06-13       Impact factor: 6.313

4.  Using Naturalistic Driving Data to Predict Mild Cognitive Impairment and Dementia: Preliminary Findings from the Longitudinal Research on Aging Drivers (LongROAD) Study.

Authors:  Xuan Di; Rongye Shi; Carolyn DiGuiseppi; David W Eby; Linda L Hill; Thelma J Mielenz; Lisa J Molnar; David Strogatz; Howard F Andrews; Terry E Goldberg; Barbara H Lang; Minjae Kim; Guohua Li
Journal:  Geriatrics (Basel)       Date:  2021-04-23

5.  Creating a driving profile for older adults using GPS devices and naturalistic driving methodology.

Authors:  Ganesh M Babulal; Cindy M Traub; Mollie Webb; Sarah H Stout; Aaron Addison; David B Carr; Brian R Ott; John C Morris; Catherine M Roe
Journal:  F1000Res       Date:  2016-09-26

Review 6.  A Systematic Review Examining Associations between Cardiovascular Conditions and Driving Outcomes among Older Drivers.

Authors:  Ganesh M Babulal; Ramana Kolady; Sarah H Stout; Catherine M Roe
Journal:  Geriatrics (Basel)       Date:  2020-04-28

7.  Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Naoki Ito; Hitomi Saito; Shinobu Seki; Fumitaka Ueda; Takashi Asada
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.